Kaya Holdings (KAYS) Amortization of Deferred Charges (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly Amortization of Deferred Charges of $531677.0 in Q3 2025, up 9377.31% quarter-over-quarter from $5610.0 in Q2 2025, and up 444.66% on a YoY basis from $97616.0 in Q3 2024.
Kaya Holdings (KAYS) Amortization of Deferred Charges (2014 - 2025) Analysis & Trends
Kaya Holdings' Amortization of Deferred Charges history runs 12 years deep, the most recent figure standing at $531677.0 for Q3 2025.
- In Q3 2025, Amortization of Deferred Charges rose 444.66% year-over-year to $531677.0; the TTM figure through Sep 2025 stood at $553029.0 (up 382.97% YoY), while the FY2024 annual figure was $119029.0, up 429.02% from the prior year.
- Amortization of Deferred Charges was $531677.0 for Q3 2025 at Kaya Holdings, up from $5610.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $531677.0 in Q3 2025 to a low of -$232724.0 in Q3 2023.
- Historically, Amortization of Deferred Charges has averaged $80585.1 across 5 years, with a median of $60113.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Amortization of Deferred Charges surged 967.55% in 2021, then plunged 3619.19% in 2023.
- A 5-year view of Amortization of Deferred Charges shows it stood at $60112.0 in 2021, then jumped by 132.2% to $139581.0 in 2022, then tumbled by 95.94% to $5671.0 in 2023, then soared by 79.76% to $10194.0 in 2024, then soared by 5115.59% to $531677.0 in 2025.
- The last three Amortization of Deferred Charges figures came in at $531677.0 (Q3 2025), $5610.0 (Q2 2025), and $5548.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 531,677.00 |
| Sep 30, 2025 | 531,677.00 |
| Jun 30, 2025 | 5,610.00 |
| Jun 30, 2025 | 5,610.00 |
| Mar 31, 2025 | 5,548.00 |
| Mar 31, 2025 | 5,548.00 |
| Dec 31, 2024 | 10,194.00 |
| Dec 31, 2024 | 10,194.00 |
| Sep 30, 2024 | 97,616.00 |
| Sep 30, 2024 | 97,616.00 |
| Jun 30, 2024 | 5,609.00 |
| Jun 30, 2024 | 5,609.00 |
| Mar 31, 2024 | 5,610.00 |
| Mar 31, 2024 | 5,610.00 |
| Dec 31, 2023 | 5,671.00 |
| Dec 31, 2023 | 5,671.00 |
| Sep 30, 2023 | -232,724.00 |
| Sep 30, 2023 | -232,724.00 |
| Jun 30, 2023 | 68,010.00 |
| Jun 30, 2023 | 68,010.00 |